Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.35 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.35 |
| ▸ | TGM2 | P21980 | 2/20 | 0.35 |
| ▸ | THRA | P10827 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | ACACB | O00763 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27574423 | 0.74 | TSHR (0.39) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL486819 | 0.73 | TGFBR1 (0.39) | TSHRALDH1A1 | |
| SCHEMBL1275466 | 0.73 | TSHR (0.38) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL15668728 | 0.73 | TSHR (0.38) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL7693137 | 0.73 | TSHR (0.42) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL8095059 | 0.72 | CA2 (0.33) | TSHRCYP3A4 | |
| SCHEMBL480327 | 0.72 | TSHR (0.41) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL1628188 | 0.72 | TSHR (0.37) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| Ammonia Solution, Strong SCHEMBL31438658 | 0.72 | TSHR (0.37) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL3279249 | 0.71 | TSHR (0.43) | TSHRALDH1A1MAPK1TDP1ZDHHC20 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10023760-B2 | Semicarbazide composition, method for producing semicarbazide composition, aqueous polymer composition and composite | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2018-07-17 | — | — | US | disclosed |
| US-9925531-B2 | Photocatalyst-supporting structure | NIPPON SODA CO., LTD. (JP) | 2018-03-27 | — | — | US | disclosed |
| US-9919301-B2 | Photocatalyst-supporting structure | NIPPON SODA CO., LTD. (JP) | 2018-03-20 | — | — | US | disclosed |
| US-20170128926-A1 | PHOTOCATALYST-SUPPORTING STRUCTURE | NIPPON SODA CO., LTD. (JP) | 2017-05-11 | — | — | US | disclosed |
| US-20150291831-A1 | SEMICARBAZIDE COMPOSITION, METHOD FOR PRODUCING SEMICARBAZIDE COMPOSITION, AQUEOUS POLYMER COMPOSITION AND COMPOSITE | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2015-10-15 | — | — | US | disclosed |
| EP-2921474-A1 | SEMICARBAZIDE COMPOSITION, METHOD FOR PRODUCING SEMICARBAZIDE COMPOSITION, AQUEOUS RESIN COMPOSITION AND COMPOSITE | Asahi Kasei Chemicals Corporation (JP) | 2015-09-23 | — | — | EP | disclosed |
| US-20140323290-A1 | PHOTOCATALYST-SUPPORTING STRUCTURE | NIPPON SODA CO., LTD. (JP) | 2014-10-30 | — | — | US | disclosed |
| EP-2783845-A1 | PHOTOCATALYST-SUPPORTING STRUCTURE | Nippon Soda Co., Ltd. (JP) | 2014-10-01 | — | — | EP | disclosed |
| US-7175892-B2 | Emulsion and coating liquid and recording medium using the same | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2007-02-13 | — | — | US | disclosed |
| US-20040115370-A1 | Emulsion and coating liquid and recording medium using the same | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2004-06-17 | — | — | US | disclosed |
| EP-1380438-A1 | EMULSION AND COATING LIQUID AND RECORDING MEDIUM USING THE SAME | Asahi Kasei Kabushiki Kaisha (JP) | 2004-01-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150291831-A1 | SEMICARBAZIDE COMPOSITION, METHOD FOR PRODUCING SEMICARBAZIDE COMPOSITION, AQUEOUS POLYMER COMPOSITION AND COMPOSITE | C9, C5, BRD2 | TSHR 3717/4885ALDH1A1 1195/4885MAPK1 4662/4885 |
| US-10023760-B2 | Semicarbazide composition, method for producing semicarbazide composition, aqueous polymer composition and composite | C9, C5, BRD2 | TSHR 3717/4885ALDH1A1 1195/4885MAPK1 4662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.